Nymox Pharm Corp (NYMXF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2004 | 12-2003 | 09-2003 | 06-2003 | 03-2003 | |
| Sales | 50 | 50 | 50 | 70 | 30 |
| Cost of Goods | 30 | 30 | 30 | 40 | 20 |
| Gross Profit | 10 | 20 | 10 | 30 | 10 |
| Operating Expenses | 990 | 1,520 | 880 | 1,170 | 940 |
| Operating Income | -940 | -1,470 | -830 | -1,100 | -910 |
| Interest Expense | 10 | 11 | 7 | 7 | 5 |
| Other Income | -10 | 1 | -3 | -13 | -5 |
| Pre-tax Income | -960 | -1,480 | -840 | -1,120 | -920 |
| Net Income Continuous | -960 | -1,480 | -840 | -1,120 | -920 |
| Net Income | $-960 | $-1,480 | $-840 | $-1,120 | $-920 |
| EBITDA(a) | $-840 | $-1,170 | $-820 | $-1,100 | $-820 |